Below are articles from various sources about members of MCB and their research.
A newly announced biotech deal shows how basic research at UC Berkeley is leading to new therapeutic approaches for cancer.
Professor Jennifer Doudna and other leading bioligists authored an article calling for a worldwide moratorium on the use of her new genome-editing technique until scientists, ethicists and the public fully understand the issues surrounding the breakthrough.
Professors Jennifer Doudna (MCB) and Montgomery Slatkin (IB), were chosen for their distinguished research excellence by the Academic Senate, and will present public lectures as part of the Martin Meyerson Faculty Research Lectures. Since 1912, these events have offered an opportunity to hear from the people who are transforming knowledge at Berkeley and in our world.